WELLS FARGO & COMPANY/MN - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 26 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q2 2022$2,000
-33.3%
1,125
-30.3%
0.00%
Q1 2022$3,0000.0%1,6140.0%0.00%
Q4 2021$3,000
-40.0%
1,614
+0.1%
0.00%
Q3 2021$5,000
+25.0%
1,613
+2.5%
0.00%
Q2 2021$4,000
-42.9%
1,574
-55.9%
0.00%
Q1 2021$7,000
-22.2%
3,571
+0.1%
0.00%
Q4 2020$9,000
-18.2%
3,569
-35.9%
0.00%
Q3 2020$11,000
-31.2%
5,569
+1.0%
0.00%
Q2 2020$16,000
-23.8%
5,516
-31.2%
0.00%
Q1 2020$21,000
-55.3%
8,016
-15.6%
0.00%
Q4 2019$47,000
-13.0%
9,500
+5.6%
0.00%
Q3 2019$54,000
+20.0%
9,000
+28.6%
0.00%
Q2 2019$45,000
+2.3%
7,000
+7.7%
0.00%
Q1 2019$44,000
+83.3%
6,500
+8.3%
0.00%
Q4 2018$24,0006,0000.00%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q4 2020
NameSharesValueWeighting ↓
Eventide Asset Management 590,602$1,577,0000.02%
TPG Group Holdings (SBS) Advisors, Inc. 1,020,748$2,725,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 23,058$62,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 110,000$294,0000.01%
Alberta Investment Management Corp 130,000$347,0000.00%
Jaffetilchin Investment Partners, LLC 11,000$29,0000.00%
TWO SIGMA INVESTMENTS, LP 164,229$438,0000.00%
TWO SIGMA ADVISERS, LP 162,942$435,0000.00%
Janney Montgomery Scott LLC 69,487$186,0000.00%
Renaissance Technologies 391,629$1,046,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders